These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 22578354)
1. [Role of non-coding RNA ANRIL in the genesis of plexiform neurofibromas in neurofibromatosis type 1]. Dereure O Ann Dermatol Venereol; 2012 May; 139(5):421-2. PubMed ID: 22578354 [No Abstract] [Full Text] [Related]
2. Role of noncoding RNA ANRIL in genesis of plexiform neurofibromas in neurofibromatosis type 1. Pasmant E; Sabbagh A; Masliah-Planchon J; Ortonne N; Laurendeau I; Melin L; Ferkal S; Hernandez L; Leroy K; Valeyrie-Allanore L; Parfait B; Vidaud D; Bièche I; Lantieri L; Wolkenstein P; Vidaud M; J Natl Cancer Inst; 2011 Nov; 103(22):1713-22. PubMed ID: 22034633 [TBL] [Abstract][Full Text] [Related]
3. Non-coding RNA ANRIL and the number of plexiform neurofibromas in patients with NF1 microdeletions. Mußotter T; Kluwe L; Högel J; Nguyen R; Cooper DN; Mautner VF; Kehrer-Sawatzki H BMC Med Genet; 2012 Oct; 13():98. PubMed ID: 23101500 [TBL] [Abstract][Full Text] [Related]
4. Non-Coding RNA and Tumor Development in Neurofibromatosis Type 1: Tritto V; Ferrari L; Esposito S; Zuccotti P; Bianchessi D; Natacci F; Saletti V; Eoli M; Riva P Genes (Basel); 2019 Nov; 10(11):. PubMed ID: 31694342 [TBL] [Abstract][Full Text] [Related]
5. Molecular profiles of neurofibromatosis type 1-associated plexiform neurofibromas: identification of a gene expression signature of poor prognosis. Lévy P; Bièche I; Leroy K; Parfait B; Wechsler J; Laurendeau I; Wolkenstein P; Vidaud M; Vidaud D Clin Cancer Res; 2004 Jun; 10(11):3763-71. PubMed ID: 15173083 [TBL] [Abstract][Full Text] [Related]
6. Large plexiform neurofibromas may be explained as a type 2 segmental manifestation of neurofibromatosis 1. Happle R Am J Med Genet; 2001 Feb; 98(4):363-4. PubMed ID: 11170084 [No Abstract] [Full Text] [Related]
7. Multiple nodular plexiform neurofibromas in a neurofibromatosis 1 family: a familial tendency? A case report and review of the literature. Tamer E; Yalçin B; Alli N Int J Dermatol; 2003 May; 42(5):357-8. PubMed ID: 12755971 [No Abstract] [Full Text] [Related]
8. Mechanisms of loss of heterozygosity in neurofibromatosis type 1-associated plexiform neurofibromas. Steinmann K; Kluwe L; Friedrich RE; Mautner VF; Cooper DN; Kehrer-Sawatzki H J Invest Dermatol; 2009 Mar; 129(3):615-21. PubMed ID: 18800150 [TBL] [Abstract][Full Text] [Related]
9. Therapy for plexiform neurofibromas in children with neurofibromatosis 1: an overview. Packer RJ; Rosser T J Child Neurol; 2002 Aug; 17(8):638-41; discussion 646-51. PubMed ID: 12403563 [TBL] [Abstract][Full Text] [Related]
10. Analysis of intratumor heterogeneity in Neurofibromatosis type 1 plexiform neurofibromas and neurofibromas with atypical features: Correlating histological and genomic findings. Carrió M; Gel B; Terribas E; Zucchiatti AC; Moliné T; Rosas I; Teulé Á; Ramón Y Cajal S; López-Gutiérrez JC; Blanco I; Castellanos E; Lázaro C; Stemmer-Rachamimov A; Romagosa C; Serra E Hum Mutat; 2018 Aug; 39(8):1112-1125. PubMed ID: 29774626 [TBL] [Abstract][Full Text] [Related]
11. Clonal origin of tumor cells in a plexiform neurofibroma with LOH in NF1 intron 38 and in dermal neurofibromas without LOH of the NF1 gene. Däschner K; Assum G; Eisenbarth I; Krone W; Hoffmeyer S; Wortmann S; Heymer B; Kehrer-Sawatzki H Biochem Biophys Res Commun; 1997 May; 234(2):346-50. PubMed ID: 9177273 [TBL] [Abstract][Full Text] [Related]
12. Plexiform Neurofibroma With Activating KRAS Mutation and Segmental Presentation Involving the Unilateral Eyelid. Stallworth JY; Smith LD; Vagefi MR; Pekmezci M Ophthalmic Plast Reconstr Surg; 2022 Jul-Aug 01; 38(4):e104-e106. PubMed ID: 35797671 [TBL] [Abstract][Full Text] [Related]
13. Severe plexiform facial neurofibromatosis, type 1 with underdeveloped eyes and a novel NF1 mutation. Kantaputra PN; van den Ouweland A; Sangruchi T; Limwongse C Am J Med Genet A; 2012 Jul; 158A(7):1750-3. PubMed ID: 22678692 [TBL] [Abstract][Full Text] [Related]
14. Chromosome 17 loss-of-heterozygosity studies in benign and malignant tumors in neurofibromatosis type 1. Rasmussen SA; Overman J; Thomson SA; Colman SD; Abernathy CR; Trimpert RE; Moose R; Virdi G; Roux K; Bauer M; Rojiani AM; Maria BL; Muir D; Wallace MR Genes Chromosomes Cancer; 2000 Aug; 28(4):425-31. PubMed ID: 10862051 [TBL] [Abstract][Full Text] [Related]
17. Mosaic Neurofibromatosis Type 1 With Multiple Cutaneous Diffuse and Plexiform Neurofibromas of the Lower Leg. Friedrich RE; Hagel C; Kohlrusch FK; Schanze I; Wieland I; Zenker M Anticancer Res; 2020 Jun; 40(6):3423-3427. PubMed ID: 32487640 [TBL] [Abstract][Full Text] [Related]
18. Differential expression of CCN1/CYR61, CCN3/NOV, CCN4/WISP1, and CCN5/WISP2 in neurofibromatosis type 1 tumorigenesis. Pasmant E; Ortonne N; Rittié L; Laurendeau I; Lévy P; Lazar V; Parfait B; Leroy K; Dessen P; Valeyrie-Allanore L; Perbal B; Wolkenstein P; Vidaud M; Vidaud D; Bièche I J Neuropathol Exp Neurol; 2010 Jan; 69(1):60-9. PubMed ID: 20010302 [TBL] [Abstract][Full Text] [Related]
19. Giant plexiform neurofibroma in a patient with neurofibromatosis type I. Rallis E; Ragiadakou D Dermatol Online J; 2009 May; 15(5):7. PubMed ID: 19624985 [TBL] [Abstract][Full Text] [Related]